No Data
No Data
Cathay Biotech Inc.'s (SHSE:688065) Share Price Could Signal Some Risk
Cathay Biotech Inc. (688065.SH) plans to distribute CNY 1.9 per 10 shares for 2023, ex-rights and ex-dividend on July 24th.
Cathay Biotech Inc. (688065.SH) announced that it plans to distribute cash to all shareholders at a rate of 10 shares per share for the year 2023.
Is Cathay Biotech (SHSE:688065) A Risky Investment?
Cathay Biotech Inc. (688065.SH): Shareholder Tianjin Sitoon and consistent actors have cumulatively reduced their shareholding by 1.518% in the company.
Cathay Biotech Inc. (688065.SH) announced on July 10 that it had received a notice letter issued by shareholder Tianjin Sitoon and concerted action Seasource on July 10, 2024. As of the disclosure date of this announcement, Tianjin Sitoon and Seasource have collectively reduced their holdings of the company's shares by 8,856,696 shares through a bulk trading method during the current shareholding reduction period, the reduction ratio of which accounted for 1.518% of the company's total share capital. Among them: Tianjin Sitoon reduced its holdings of the company's shares by 8,656,696 shares through bulk trading, the reduction ratio of which accounted for 1.48% of the company's total share capital.
Cathay Biotech Inc. (688065.SH): accumulated buyback of 0.1629% of shares.
Cathay Biotech Inc. (688065.SH) announced on July 1st that as of June 30th, 2024, the company repurchased 950,464 shares of the company's stock through the Shanghai Stock Exchange trading system with a centralized bidding trading method, accounting for 0.1629% of the company's total share capital of 583,378,039 shares. The highest price for repurchase was 57.37 yuan/share and the lowest was 38.98 yuan/share, with a total amount of CNY 49,415,764.27 (excluding stamp duty, transaction commissions and other transaction costs).
Some Investors May Be Worried About Cathay Biotech's (SHSE:688065) Returns On Capital
No Data